Cingulate Inc (CING)
4.25
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 14, 16:00
4.25
0.00 (0.00%)
After-Hours: 16:40
Cingulate Enterprise Value: 3.725M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 3.725M |
| November 12, 2024 | 3.583M |
| November 11, 2024 | 3.915M |
| November 08, 2024 | 2.917M |
| November 07, 2024 | 2.889M |
| November 06, 2024 | 2.813M |
| November 05, 2024 | 3.088M |
| November 04, 2024 | 3.260M |
| November 01, 2024 | 3.278M |
| October 31, 2024 | 3.459M |
| October 30, 2024 | 3.668M |
| October 29, 2024 | 3.792M |
| October 28, 2024 | 3.744M |
| October 25, 2024 | 3.773M |
| October 24, 2024 | 4.020M |
| October 23, 2024 | 4.058M |
| October 22, 2024 | 4.552M |
| October 21, 2024 | 4.296M |
| October 18, 2024 | 3.982M |
| October 17, 2024 | 3.887M |
| October 16, 2024 | 3.801M |
| October 15, 2024 | 3.849M |
| October 14, 2024 | 3.906M |
| October 11, 2024 | 4.220M |
| October 10, 2024 | 3.849M |
| Date | Value |
|---|---|
| October 09, 2024 | 3.744M |
| October 08, 2024 | 3.896M |
| October 07, 2024 | 4.248M |
| October 04, 2024 | 4.191M |
| October 03, 2024 | 4.200M |
| October 02, 2024 | 4.191M |
| October 01, 2024 | 4.296M |
| September 30, 2024 | 4.410M |
| September 27, 2024 | 4.400M |
| September 26, 2024 | 4.505M |
| September 25, 2024 | 4.514M |
| September 24, 2024 | 4.381M |
| September 23, 2024 | 4.486M |
| September 20, 2024 | 4.562M |
| September 19, 2024 | 4.505M |
| September 18, 2024 | 4.314M |
| September 17, 2024 | 4.533M |
| September 16, 2024 | 4.324M |
| September 13, 2024 | 4.752M |
| September 12, 2024 | 5.265M |
| September 11, 2024 | 5.807M |
| September 10, 2024 | 4.799M |
| September 09, 2024 | 4.837M |
| September 06, 2024 | 5.246M |
| September 05, 2024 | 5.341M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.381M
Minimum
Mar 08 2022
48.74M
Maximum
Dec 08 2021
8.762M
Average
7.634M
Median
Enterprise Value Benchmarks
| United Therapeutics Corp | 14.96B |
| Tonix Pharmaceuticals Holding Corp | 7.437M |
| Geovax Labs Inc | 12.79M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.210M |
| Total Expenses (Quarterly) | 3.206M |
| EPS Diluted (Quarterly) | -65.64 |
| Earnings Yield | -5.09K% |